Importantly, we also found that SOX2, a well-known GBM cell stemness marker, is almost undetectable in the SON shRNA-expressing tumor section while control tumors showed robust SOX2 expression (Fig. 8e). This evidence concerns the gene SOX2 and glioblastoma.